Viridian TherapeuticsVRDN 
$21.06-0.57%24h
-0.57%24h
Global rank7386
Market cap$1.11B
Change 7d39.84%
YTD Performance-1.86%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Viridian Therapeutics (VRDN)
As of November 2024, Viridian Therapeutics has a market cap of $1.11B. This makes Viridian Therapeutics the world's 7386th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Viridian Therapeutics from 2014 to 2024
-
Value:-
Market cap history of Viridian Therapeutics from 2014 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $983.36M | -14.14% |
| 2023 | $1.15B | -25.44% |
| 2022 | $1.54B | 47.75% |
| 2021 | $1.04B | 20.18% |
| 2020 | $865.04M | 128.47% |
| 2019 | $378.62M | -84.16% |
| 2018 | $2.39B | -70.95% |
| 2017 | $8.23B | 108.18% |
| 2016 | $3.95B | -55.35% |
| 2015 | $8.85B | -70.55% |
| 2014 | $30.05B | - |
VRDN Market Cap Today is $1.11B -0.57% - 1 Nov 2024
View largest stocks by market cap 
